A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2000
This study will compare kidney function in kidney transplant patients following treatment with various combinations of Zenapax, CellCept, corticosteroids, and Neoral (Cyclosporine). The anticipated time on study treatment is 6-12 months, and the target sample size is 500+ individuals.
Epistemonikos ID: 93d1d7e1fc46e38b5743ace5472bf52fae05b925
First added on: May 04, 2024